Matches in Wikidata for { <http://www.wikidata.org/entity/Q91554066> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q91554066 description "article scientifique (publié 2018)" @default.
- Q91554066 description "articolo scientifico (pubblicato il 2018)" @default.
- Q91554066 description "artigo científico (publicado na 2018)" @default.
- Q91554066 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q91554066 description "artículo científico publicado en 2018" @default.
- Q91554066 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q91554066 description "im Januar 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91554066 description "scientific article published on 01 January 2018" @default.
- Q91554066 description "wetenschappelijk artikel" @default.
- Q91554066 description "наукова стаття, опублікована 1 січня 2018" @default.
- Q91554066 description "научна статия" @default.
- Q91554066 name "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 name "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 name "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 type Item @default.
- Q91554066 label "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 label "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 label "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 prefLabel "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 prefLabel "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 prefLabel "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 P1433 Q91554066-52BFF1F3-6DFE-4E0B-B53E-8078AC22966B @default.
- Q91554066 P1476 Q91554066-0202809E-A6D4-4F96-A200-FC6C2D2C39E3 @default.
- Q91554066 P2093 Q91554066-1140195A-8E61-48B3-AF3F-26AA55C22F39 @default.
- Q91554066 P2093 Q91554066-20B9F8E7-CA2A-4C7A-AFD9-8A62ECC65600 @default.
- Q91554066 P2093 Q91554066-226786F1-B0A0-4DCA-B1B4-D3FF1917363C @default.
- Q91554066 P2093 Q91554066-2BE3D9F8-FF1A-45AB-B479-75A20692EAA3 @default.
- Q91554066 P2093 Q91554066-4B0EC6BA-F231-46DF-8D86-D23E83031526 @default.
- Q91554066 P2093 Q91554066-5A02D6D3-DFAF-46FB-9E0F-EDA5EFE194B0 @default.
- Q91554066 P2093 Q91554066-693D3F31-1AE0-4F54-BCC5-13FA1EE0F330 @default.
- Q91554066 P2093 Q91554066-6E396CE4-451A-4AD0-8F65-C444587864D6 @default.
- Q91554066 P2093 Q91554066-7FBF7E5F-6DB6-41F7-A629-01371101603B @default.
- Q91554066 P2093 Q91554066-8ADE29B3-60E8-4DF8-8DD4-29D321232E4C @default.
- Q91554066 P2093 Q91554066-A4104D88-0F4A-4630-AECA-F5DE1B082777 @default.
- Q91554066 P2093 Q91554066-A59078C7-C87D-457A-A808-D265E1FC5E0E @default.
- Q91554066 P2093 Q91554066-AB70ACA6-4358-4581-9583-628748FEE50A @default.
- Q91554066 P2093 Q91554066-E22BF85F-0DFA-4515-B047-321B1FA7E522 @default.
- Q91554066 P2093 Q91554066-E991FEF4-DC73-4B1F-B16D-FAAAB6BC9806 @default.
- Q91554066 P2093 Q91554066-F63DCC26-419A-4DCC-81F0-3F72A740037B @default.
- Q91554066 P304 Q91554066-29D9B8C2-F02C-4D65-8FE1-6B07472243DC @default.
- Q91554066 P31 Q91554066-B91CE4BC-3953-4ADE-968D-00B0C4592B96 @default.
- Q91554066 P356 Q91554066-36071C52-765C-4E77-B14C-11164AFC8770 @default.
- Q91554066 P433 Q91554066-DDBD4320-6744-4D2E-84D6-6185720A9DB5 @default.
- Q91554066 P478 Q91554066-386A5072-EC09-4FAA-88C1-E721D777081B @default.
- Q91554066 P50 Q91554066-EBEA273C-BCF9-4349-A033-F09ED699BB7C @default.
- Q91554066 P577 Q91554066-50219062-65E2-4D18-AC7A-EAF1E30C7A2E @default.
- Q91554066 P698 Q91554066-622280DF-AFD0-4AF6-B48D-C07751071D5B @default.
- Q91554066 P932 Q91554066-8C4881D7-49BE-410A-A3BE-47F106447769 @default.
- Q91554066 P356 1570162X17666190212163518 @default.
- Q91554066 P698 30760189 @default.
- Q91554066 P1433 Q5195049 @default.
- Q91554066 P1476 "Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study" @default.
- Q91554066 P2093 "A Antela" @default.
- Q91554066 P2093 "A Casado" @default.
- Q91554066 P2093 "A Muñoz" @default.
- Q91554066 P2093 "A Romero" @default.
- Q91554066 P2093 "C Miralles" @default.
- Q91554066 P2093 "D Podzamczer" @default.
- Q91554066 P2093 "E Deig" @default.
- Q91554066 P2093 "E Rodríguez de Castro" @default.
- Q91554066 P2093 "E Van den Eynde" @default.
- Q91554066 P2093 "For The Pro-Str Study Group" @default.
- Q91554066 P2093 "H Knobel" @default.
- Q91554066 P2093 "J Pasquau" @default.
- Q91554066 P2093 "M A Casado" @default.
- Q91554066 P2093 "N Rozas" @default.
- Q91554066 P2093 "P Domingo" @default.
- Q91554066 P2093 "P Geijo" @default.
- Q91554066 P304 "425-435" @default.
- Q91554066 P31 Q13442814 @default.
- Q91554066 P356 "10.2174/1570162X17666190212163518" @default.
- Q91554066 P433 "6" @default.
- Q91554066 P478 "16" @default.
- Q91554066 P50 Q20100355 @default.
- Q91554066 P577 "2018-01-01T00:00:00Z" @default.
- Q91554066 P698 "30760189" @default.
- Q91554066 P932 "6700757" @default.